Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2014, Article ID 837835, 11 pages
http://dx.doi.org/10.1155/2014/837835
Research Article

Beneficial Effects of Fractions of Nardostachys jatamansi on Lipopolysaccharide-Induced Inflammatory Response

1Hanbang Body-Fluid Research Center, Wonkwang University, Iksan, Jeonbuk 540-749, Republic of Korea
2Department of Rehabilitation Medicine of Korean Medicine, Spine & Joint Center, Pusan National University Korean Medicine Hospital, Yangsan 626-770, Republic of Korea
3Department of Herbology, School of Oriental Medicine, Wonkwang University, Iksan, Jeonbuk 540-749, Republic of Korea
4BK21 plus team, Professional Graduate School of Oriental Medicine, Wonkwang University, Iksan, Jeonbuk 540-749, Republic of Korea
5Department of Beauty, Dongshin University, Naju, Jeonnam 252-17, Republic of Korea
6College of Pharmacy, Wonkwang University, Iksan 570-749, Republic of Korea

Received 19 November 2013; Revised 28 February 2014; Accepted 3 March 2014; Published 30 March 2014

Academic Editor: MinKyun Na

Copyright © 2014 Gi-Sang Bae et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C.-S. Sung and C.-S. Wong, “Cellular mechanisms of neuroinflammatory pain: the role of interleukin-1β,” Acta Anaesthesiologica Taiwanica, vol. 45, no. 2, pp. 103–109, 2007. View at Google Scholar · View at Scopus
  2. F. O. Martinez, L. Helming, and S. Gordon, “Alternative activation of macrophages: an immunologic functional perspective,” Annual Review of Immunology, vol. 27, pp. 451–483, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. J. D. Schilling, H. M. Machkovech, L. He, A. Diwan, and J. E. Schaffer, “TLR4 activation under lipotoxic conditions leads to synergistic macrophage cell death through a TRIF-dependent pathway,” Journal of Immunology, vol. 190, no. 3, pp. 1285–1296, 2013. View at Google Scholar
  4. Y. Ben-Neriah and M. Karin, “Inflammation meets cancer, with NF-κB as the matchmaker,” Nature Immunology, vol. 12, no. 8, pp. 715–723, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. B. C. Bose, Y. Vijayvargiya, and J. N. Bhatnagar, “Nardostachys jatamansi DC: a phyto-chemical study of its active constituents,” Indian Journal of Medical Sciences, vol. 11, no. 10, pp. 799–802, 1957. View at Google Scholar · View at Scopus
  6. G.-S. Bae, H.-J. Park, D.-Y. Kim et al., “Nardostachys jatamansi protects against cerulein-induced acute pancreatitis,” Pancreas, vol. 39, no. 4, pp. 520–529, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. G.-S. Bae, S.-W. Seo, M.-S. Kim et al., “The roots of Nardostachys jatamansi inhibits lipopolysaccharide-induced endotoxin shock,” Journal of Natural Medicines, vol. 65, no. 1, pp. 63–72, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. G. S. Bae, K. C. Park, B. S. Koo et al., “The inhibitory effects of Nardostachys jatamansi on alcoholic chronic pancreatitis,” BMB Reports, vol. 45, no. 7, pp. 402–407, 2012. View at Google Scholar
  9. G. S. Bae, K. C. Park, B. S. Koo et al., “The beneficial effects of Nardostachys jatamansi extract on diet-induced severe acute pancreatitis,” Pancreas, vol. 42, no. 2, pp. 362–363, 2013. View at Google Scholar
  10. M.-Y. Song, U.-J. Bae, B.-H. Lee et al., “Nardostachys jatamansi extract protects against cytokineinduced β-cell damage and streptozotocin-induced diabetes,” World Journal of Gastroenterology, vol. 16, no. 26, pp. 3249–3257, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. G. S. Bae, M. S. Kim, K. C. Park et al., “Effect of biologically active fraction of Nardostachys jatamansi on cerulein-induced acute pancreatitis,” World Journal of Gastroenterology, vol. 18, no. 25, pp. 3223–3234, 2012. View at Google Scholar
  12. R. S. Hotchkiss and I. E. Karl, “The pathophysiology and treatment of sepsis,” The New England Journal of Medicine, vol. 348, no. 2, pp. 138–150, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. T. S. Blackwell and J. W. Christman, “Sepsis and cytokines: current status,” British Journal of Anaesthesia, vol. 77, no. 1, pp. 110–117, 1996. View at Google Scholar · View at Scopus
  14. H. B. Jijon, W. J. Panenka, K. L. Madsen, and H. G. Parsons, “MAP kinases contribute to IL-8 secretion by intestinal epithelial cells via a posttranscriptional mechanism,” American Journal of Physiology—Cell Physiology, vol. 283, no. 1, pp. C31–C41, 2002. View at Google Scholar · View at Scopus
  15. M. Sánchez-Hidalgo, A. R. Martín, I. Villegas, and C. Alarcón de la Lastra, “Rosiglitazone, a PPARγ ligand, modulates signal transduction pathways during the development of acute TNBS-induced colitis in rats,” European Journal of Pharmacology, vol. 562, no. 3, pp. 247–258, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. F. Scaldaferri, M. Sans, S. Vetrano et al., “The role of MAPK in governing lymphocyte adhesion to and migration across the microvasculature in inflammatory bowel disease,” European Journal of Immunology, vol. 39, no. 1, pp. 290–300, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Chae, L. Eckmann, Y. Miyamoto, C. Pothoulakis, M. Karin, and M. F. Kagnoff, “Epithelial cell IκB-kinase β has an important protective role in Clostridium difficile toxin A-induced mucosal injury,” Journal of Immunology, vol. 177, no. 2, pp. 1214–1220, 2006. View at Google Scholar · View at Scopus